Ob/Gyn Panel Illuminates Luma Trial Design Problem Areas For MediSpectra
This article was originally published in The Gray Sheet
Executive Summary
MediSpectra should design and perform a new study to address more closely the specific indication in the firm's PMA for the Luma cervical imager, according to FDA's Obstetrics & Gynecology Devices Panel